These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27749737)

  • 21. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
    Kalla Singh S; Tan QW; Brito C; De León M; De León D
    Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women.
    Agurs-Collins T; Adams-Campbell LL; Kim KS; Cullen KJ
    Cancer Detect Prev; 2000; 24(3):199-206. PubMed ID: 10975280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium.
    Bandera EV; Chandran U; Hong CC; Troester MA; Bethea TN; Adams-Campbell LL; Haiman CA; Park SY; Olshan AF; Ambrosone CB; Palmer JR; Rosenberg L
    Breast Cancer Res Treat; 2015 Apr; 150(3):655-66. PubMed ID: 25809092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
    Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body size in early life and breast cancer risk in African American and European American women.
    Bandera EV; Chandran U; Zirpoli G; Ciupak G; Bovbjerg DH; Jandorf L; Pawlish K; Freudenheim JL; Ambrosone CB
    Cancer Causes Control; 2013 Dec; 24(12):2231-43. PubMed ID: 24113797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in breast cancer survival in women under age 60.
    Sarker M; Jatoi I; Becher H
    Breast Cancer Res Treat; 2007 Nov; 106(1):135-41. PubMed ID: 17295046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
    Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
    JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
    Morimoto LM; White E; Chen Z; Chlebowski RT; Hays J; Kuller L; Lopez AM; Manson J; Margolis KL; Muti PC; Stefanick ML; McTiernan A
    Cancer Causes Control; 2002 Oct; 13(8):741-51. PubMed ID: 12420953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.
    DeSantis CE; Siegel RL; Sauer AG; Miller KD; Fedewa SA; Alcaraz KI; Jemal A
    CA Cancer J Clin; 2016 Jul; 66(4):290-308. PubMed ID: 26910411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial differences in anthropometric measures as risk factors for triple-negative breast cancer.
    Wang F; Kroenke CH; Pan K; Shadyab AH; Chlebowski RT; Wactawski-Wende J; Qi L; Luo J
    Cancer Causes Control; 2022 Dec; 33(12):1413-1419. PubMed ID: 36129619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study.
    Jernström H; Barrett-Connor E
    J Womens Health Gend Based Med; 1999 Dec; 8(10):1265-72. PubMed ID: 10643834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Black-White Disparities in Breast and Colorectal Cancer Screening Rates in a Changing Screening Environment: The Peters-Belson Approach Using United States National Health Interview Surveys 2000-2010.
    Rao SR; Breen N; Graubard BI
    Med Care; 2016 Feb; 54(2):133-9. PubMed ID: 26565527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
    Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
    Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
    Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.